New Search

If you are not happy with the results below please do another search

Generic filters

50 search results for:


Open Innovation’s Role in Development and Go-to-Market Strategies

Dr. Bethany Valente, founder and managing partner of Tempo7 LLC, discusses the challenges that biotech and pharma-based businesses face as they work to create more efficient development time frames for product, therapy, or drug development. Dr. Valente says open innovation helps in resolving some of these challenges.


FDA Grants Accelerated Approval for Tivdak in Previously Treated Recurrent or Metastatic Cervical Cancer

Genmab A/S and Seagen Inc. announced that the U.S. Food and Drug Administration granted accelerated approval to Tivdak (tisotumab vedotin-tftv), the first approved antibody-drug conjugate for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.